MyFinsight
Home
Blog
About
Cash and cash
equivalents
$109,528K
(-28.38%↓ Y/Y)
Prepaid expenses and
other current assets
$1,340K
(2.06%↑ Y/Y)
Accrued interest
receivable
$277K
(-42.29%↓ Y/Y)
Income tax receivable
$14K
(-91.14%↓ Y/Y)
Total current assets
$111,159K
(-28.23%↓ Y/Y)
Property and equipment,
net
$22,492K
(-5.47%↓ Y/Y)
Total assets
$133,651K
(-25.20%↓ Y/Y)
Total liabilities and
shareholders equity
$133,651K
(-25.20%↓ Y/Y)
Total shareholders
equity
$128,461K
(-25.77%↓ Y/Y)
Total liabilities
$5,190K
(-7.62%↓ Y/Y)
Accumulated deficit
-$148,610K
(-43.62%↓ Y/Y)
Common stock, no par
value, unlimited...
$277,071K
(0.19%↑ Y/Y)
Total current
liabilities
$3,353K
(-13.07%↓ Y/Y)
Income tax payable
$1,832K
(4.03%↑ Y/Y)
Deferred tax liability
$5K
Accrued expenses
$2,248K
(-6.72%↓ Y/Y)
Accounts payable
$1,105K
(-22.78%↓ Y/Y)
Back
Back
Balance Sheet
XBiotech Inc. (XBIT)
XBiotech Inc. (XBIT)
source: myfinsight.com